Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Schimmelpfeng J et al. | 1993 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) | electric field, magnetic field, 50/60 Hz | 2 mT |
Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Colciago A et al. | 2024 | intact cell/cell culture, Schwann cells (from sciatic nerves of neonatal rats) | magnetic field, 50/60 Hz | - |
Su L et al. | 2017 | intact cell/cell culture, U251 and A127 (human glioblastoma cell lines), SH-SY5Y (human neuroblastoma cell line), rat astrocytes, rat microglia, primary cortical neurons (of rat) | magnetic field, low frequency, 50/60 Hz | 2 mT |
Akbarnejad Z et al. | 2017 | intact cell/cell culture, U87 (human glioblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 5–10 mT |
Saalman E et al. | 1991 | intact cell/cell culture, V79 (Chinese hamster fibroblast cells) | magnetic field, 50/60 Hz | 30 µT |
Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
Ma Q et al. | 2014 | intact cell/cell culture, embryonic neural stem cells (mouse/BALB/c) | magnetic field, 50/60 Hz | 0.5–2 mT |
Sul AR et al. | 2006 | intact cell/cell culture, hFOB 1.19 (human fetal osteoblasts), T/G HA-VSMC (human aortic vascular smooth muscle cells), RPMI 7666 (human B lymphoblasts) and HCN-2 (human cortical neuronal cells) | magnetic field, 50/60 Hz | 2 mT |
Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.